Form D · Biotechnology
I2Pure Corp.
Ashburn, VA · CIK 0001957827
Offering snapshot reported Dec 12, 2022 · SEC filing
- Reported sold
- $300K Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Nov 25, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2022 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-467134
Convertible Debt
Source: Form D, filed Dec 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Kessler | Director |
| Lee Larson | Director |
| Rob Painter | Director, Executive |
| Douglas Spitz | Director, Executive |
| Joseph Steinberg | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
44679 Endicott Drive Suite 300
Ashburn, VA, 20147
Ashburn, VA, 20147